Snowden Capital Advisors LLC Repligen Corp Transaction History

Snowden Capital Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$138.42 - $180.31 $4,983 - $6,491	36 Added 2.35%	1,565 $221,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $12,803 - $16,442	-83 Reduced 5.15%	1,529 $257,000
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $2.06 Million - $2.79 Million	-12,668 Reduced 88.71%	1,612 $272,000
Q3 2022 Nov 09, 2022	BUY	$160.42 - $256.21 $2.03 Million - $3.25 Million	12,667 Added 785.31%	14,280 $2.67 Million
Q2 2022 Aug 12, 2022	BUY	$140.68 - $188.02 $20,539 - $27,450	146 Added 9.95%	1,613 $261,000
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $220,991 - $353,663	1,371 Added 1428.13%	1,467 $275,000
Q4 2021 Feb 14, 2022	BUY	$247.59 - $304.47 $23,768 - $29,229	96 New	96 $25,000
Q2 2021 Jan 08, 2024	SELL	$165.87 - $220.95 $5.09 Million - $6.77 Million	-30,660 Closed	0 $0
Q1 2021 Jan 08, 2024	BUY	$180.37 - $226.26 $412,145 - $517,004	2,285 Added 8.05%	30,660 $5.96 Billion
Q4 2020 Jan 08, 2024	BUY	$148.08 - $206.57 $139,639 - $194,795	943 Added 3.44%	28,375 $5.44 Billion
Q3 2020 Jan 08, 2024	BUY	$122.51 - $158.27 $1.6 Million - $2.07 Million	13,060 Added 90.87%	27,432 $4.05 Billion
Q2 2020 Jan 08, 2024	BUY	$94.33 - $140.48 $1.36 Million - $2.02 Million	14,372 New	14,372 $1.78 Billion

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.